Related Experiment Video

Updated: May 15, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Regenerative medicine for the treatment of heart disease

E M Hansson1, U Lendahl

  • 1Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. ehansson@partners.org

Journal of Internal Medicine
|January 22, 2013
PubMed

Insights

Stem cell therapy offers hope for heart failure, a leading cause of death. This review explores stem and progenitor cell treatments and endogenous regenerative strategies for heart disease.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Heart failure is a significant global health concern with increasing prevalence.
  • Current treatments, including heart transplantation, are limited in scope.
  • Replacing lost cardiomyocytes via stem cells or endogenous regeneration is a promising therapeutic avenue.

Purpose of the Study:

  • To review the current status of stem and progenitor cell-based therapies for heart disease.
  • To discuss the advantages and disadvantages of various stem cell types for cardiac transplantation.
  • To explore advancements in cardiomyocyte differentiation and ex vivo generation.

Main Methods:

  • Literature review of stem cell therapies for heart failure.
  • Analysis of cardiomyocyte differentiation and generation processes.
  • Evaluation of endogenous stem cell activation strategies.

Main Results:

  • Stem and progenitor cell transplantation is a key focus for heart failure treatment.
  • Understanding cardiomyocyte differentiation aids in generating new cells ex vivo.
  • Activating endogenous stem cells presents another potential therapeutic approach.

Conclusions:

  • Stem cell-based therapies hold significant potential for treating heart failure.
  • Further research into cell types, differentiation, and endogenous activation is crucial.
  • Regenerative medicine offers new hope for patients with heart disease.

More Related Videos

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction07:41

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction

Published on: June 7, 2011

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets09:24

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Published on: October 3, 2014

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...